ALT-100 (Human IgG1)
ALT-100 (Human IgG1) is a humanized IgG1 monoclonal antibody that targets NAMPT. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control[2].
Product Specifications
UNSPSC
12352203
Target
NAMPT
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
99.90
Smiles
[ALT-100(HumanIgG1)]
Molecular Weight
(144.9 kDa)
References & Citations
[1]Liu Z, et al. An eNAMPT-neutralizing mAb reduces post-infarct myocardial fibrosis and left ventricular dysfunction. Biomed Pharmacother. 2024 Jan;170:116103.|[2]Joe G.N, et al. Anti-nampt antibodies and uses thereof. WO2021026508A1. 2021-02-11.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
